Table III.
Univariate | Multivariate | |||
---|---|---|---|---|
Variable | HR (95% CI) | P-value | HR (95% CI) | P-value |
Gender (male, vs. female) | 0.624 (0.383–1.017) | 0.059 | ||
Age (≤64, vs. >64 years) | 0.929 (0.593–1.456) | 0.749 | ||
Smoking status (never, vs. current/former) | 2.012 (1.254–3.229) | 0.004 | 1.172 (0.682–2.012) | 0.566 |
Histology (adenocarcinoma, vs. squamous) | 2.168 (1.273–3.695) | 0.004 | 1.111 (0.670–1.844) | 0.747 |
Histological differentiation (well, vs. poor) | 0.873 (0.535–1.424) | 0.586 | ||
Lymph node metastasis (yes, vs. no) | 2.576 (1.493–4.443) | 0.001 | 2.400 (1.353–4.257) | 0.003 |
Distant metastasis (yes, vs. no) | 1.294 (0.824–2.032) | 0.264 | ||
EGFR (mutated, vs. wild type) | 0.238 (0.139–0.409) | <0.001 | 0.284 (0.150–0.537) | <0.001 |
Estrogen receptor-β (positive, vs. negative) | 1.924 (1.197–3.092) | 0.007 | 1.111 (0.670–1.844) | 0.684 |
P53 (positive, vs. negative) | 1.102 (0.698–1.738) | 0.678 |
EGFR, epidermal growth factor receptor; HR, hazard ratio; CI, confidence interval.